Latest Content

10 Commonly Asked Lung Cancer Questions With Dr. Jyoti Malhotra

September 25th 2024, 7:00pm

By Kristie L. Kahl

Article

Following a CURE® Educated Patient® Lung Cancer Summit, the City of Hope expert answered 10 commonly asked questions from patients with lung cancer.

Bringing Awareness to Depression and Cancer

September 25th 2024, 5:10pm

By Joe Bullock

Article

Before receiving my colorectal cancer diagnosis, I had experienced cancer. However, my depression felt different during treatment.

Study Suggests Using Caution With ChatGPT for Breast Cancer Information

September 25th 2024, 3:00pm

By Spencer Feldman

Article

When given commonly asked questions regarding breast cancer, ChatGPT’s answers were incorrect a quarter of the time and often provided fake references.

Survival Benefit Continues at 10 Years From Opdivo Either Alone or With Yervoy in Advanced Melanoma

September 25th 2024, 1:00pm

By Gina Mauro

Article

Findings from the CheckMate 067 of patients with advanced melanoma include the longest follow-up of a checkpoint inhibitor in any tumor type.

Krazati Associated With Superior Outcomes Than Docetaxel in KRAS G12C+ NSCLC

September 24th 2024, 9:00pm

By Alex Biese

Article

Krazati’s benefits were seen regardless of baseline brain metastases, researchers have reported in findings from the KRYSTAL-12 trial.

Kidney Cancer FAQs Answered on Treatments, Care Teams and More

September 24th 2024, 7:00pm

By Alex Biese

Article

An expert provides answers to pressing questions regarding different aspects of a kidney cancer journey, including stage, grade and treatment options.

Navigating the Cancer Journey With Two Different Approaches

September 24th 2024, 5:00pm

By Sue McCarthy

Article

Two vastly different approaches to navigating the cancer journey may or may not be mutually exclusive.

Reblozyl May Be ‘The Standard of Care’ Now in Lower-Risk MDS, Anemia

September 24th 2024, 3:00pm

By Alex Biese

Article

An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS.

Imfinzi Improves Survival Outcomes in Subgroups of Patients with LS-SCLC

September 24th 2024, 1:00pm

By Russ Conroy

Article

Among patients with limited-stage small cell lung cancer, the benefits of consolidation Imfinzi were seen across a number of subgroups.

Nubeqa Plus ADT Outperformed ADT Alone in Treating Prostate Cancer

September 23rd 2024, 9:00pm

By Jonah Feldman

Article

Adding Nubeqa to androgen deprivation therapy improved radiographic progression-free survival in patients with metastatic hormone-sensitive prostate cancer.

Outpatient CAR-T Cell Therapy May Be Safe in Hematologic Malignancies

September 23rd 2024, 7:00pm

By Spencer Feldman

Article

CAR-T cell therapies administered in an outpatient setting may be safe and feasible without intensive remote monitoring in hematologic malignancies.

Meeting New People and Finding Old Assumptions After Cancer

September 23rd 2024, 5:00pm

By Karen Cohn

Article

Recently, I met a fellow cancer survivor but after talking with her about cancer, I realized she had a different perspective than I did.

Steatotic Liver Disease Linked to Improved Survival in Patients With Liver Cancer

September 23rd 2024, 3:00pm

By Spencer Feldman

Article

Steatotic liver disease was associated with better liver function, lower recurrence rates, and improved overall survival in patients with liver cancer who received radiofrequency ablation.

Enhertu Maintains QOL, Slows Pain in HR+/HER2 Metastatic Breast Cancer

September 23rd 2024, 1:00pm

By Jonah Feldman

Article

Enhertu improved the time it took for patients with a breast cancer subset to experience worsening pain and other symptoms, without affecting overall quality of life.

Patients with Extensive-Stage SCLC May Benefit From Higher I-DXd Dose

September 22nd 2024, 3:00pm

By Ashley Chan

Article

A recent study compared two dosages of ifinatamab deruxtecan among patients with extensive-stage small cell lung cancer.